These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11027924)

  • 1. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
    Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
    Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of antidepressants in patients with Parkinson disease and depression.
    Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
    Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief.
    Zygmont M; Prigerson HG; Houck PR; Miller MD; Shear MK; Jacobs S; Reynolds CF
    J Clin Psychiatry; 1998 May; 59(5):241-5. PubMed ID: 9632035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine.
    Gilmor ML; Owens MJ; Nemeroff CB
    Am J Psychiatry; 2002 Oct; 159(10):1702-10. PubMed ID: 12359676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.
    Mulsant BH; Pollock BG; Nebes RD; Miller MD; Little JT; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 1999; 60 Suppl 20():16-20. PubMed ID: 10513853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
    Lotrich FE; Pollock BG; Kirshner M; Ferrell RF; Reynolds Iii CF
    J Psychiatry Neurosci; 2008 Mar; 33(2):123-30. PubMed ID: 18330458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
    Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.
    Rausch JL; Johnson ME; Fei YJ; Li JQ; Shendarkar N; Hobby HM; Ganapathy V; Leibach FH
    Biol Psychiatry; 2002 May; 51(9):723-32. PubMed ID: 11983186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years.
    Walters G; Reynolds CF; Mulsant BH; Pollock BG
    J Clin Psychiatry; 1999; 60 Suppl 20():21-5. PubMed ID: 10513854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderation of antidepressant response by the serotonin transporter gene.
    Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
    Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
    Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
    Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
    Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.
    Nelson JC; Kennedy JS; Pollock BG; Laghrissi-Thode F; Narayan M; Nobler MS; Robin DW; Gergel I; McCafferty J; Roose S
    Am J Psychiatry; 1999 Jul; 156(7):1024-8. PubMed ID: 10401446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
    Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
    Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
    Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
    Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.